Drug-excipient interactions in ketoprofen: A vibrational spectroscopy study

Biopolymers

Volumn 82, Issue 4, 2006, Pages 420-424

  Batista De Carvalho, L A E ^a   Marques, M Paula M ^a,b,d   Tomkinson, John ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c RUTHERFORD APPLETON LABORATORY   (United Kingdom)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Drug excipient interactions; Inelastic neutron scattering; Ketoprofen; Raman

Indexed keywords

CARBOXYLIC ACIDS; DRUG PRODUCTS; GLUCOSE; NEUTRON SCATTERING; SPECTROSCOPIC ANALYSIS;

DRUG-EXCIPIENT INTERACTIONS; INELASTIC NEUTRON SCATTERING; KETOPROFEN; TERMINAL METHYL-CARBOXYLIC MOIETIES;

ACETIC ACID;

KETOPROFEN; LACTOSE; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE;

AGING; ARTICLE; MEDICAL LITERATURE; MEDICAL RESEARCH; NEUTRON SCATTERING; RAMAN SPECTROMETRY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ELASTICITY; EXCIPIENTS; KETOPROFEN; LACTOSE; NEUTRON DIFFRACTION; POVIDONE; SPECTRUM ANALYSIS, RAMAN;

EID: 33745699043     PISSN: 00063525     EISSN: 10970282     Source Type: Journal    
DOI: 10.1002/bip.20517     Document Type: Article

References (20)

1. Cathcart, B. J.; Vince, J. D.; Gordon, A. J.; Bell, M.; Chalmers, I. M. Ann Reum Dis 1973, 32, 62-65.
2. Fossgreen, J. Scand J Rheumatol Suppl 1976, 14, 7-32.
3. Julou, J.; Guyonnet, J. C.; Ducrot, R.; Fournel, J.; Pasquet, J. Scand J Rheumatol Suppl 1976, 14, 33-44.
4. Avouac, B.; Teule, M. J Clin Pharmacol 1988, 28, S2-S7.
5. Vargaftig, B. B.; Dao, N. Pharmacology, 1971, 6, 99-108.
6. Sweetman, S. C. In Martindale: The Complete Drug Reference, 32th ed.; Parfitt, K., Ed.; The Pharmaceutical Press: London, 1999; pp 48-49.
7. Vergote, G. J.; Vervaet, C.; Van Driessche, I.; Hoste, S.; De Smedt, S.; Demeester, J.; Jain, R. A.; Ruddy, S.; Remon, J. P. Int J Pharm 2001, 219, 81-87.
8. Palmieri, G. F.; Bonacucina, G.; DiMartino, P.; Martilli, S. Int J Pharm 2002, 242, 175-178.
9. Roda, A.; Sabatini, L.; Mirasoli, M.; Baraldini, M.; Roda, E. Int J Pharm 2002, 241, 165-172.
10. Hamdani, J.; Moes, A. J.; Amighi, K. Int J Pharm 2002, 245, 167-177.
11. Gupta, M. K.; Tseng, Y. C.; Goldman, D.; Bogner, R. H. Pharm Res 2002, 19, 1663-1672.
12. Granero, G.; Longhi, M. Pharm Dev Technol 2002, 7, 381-390.
13. Akers, M. J. J Pharm Sci. 2002, 91, 2283-2300.
14. Scranton, A. B.; Drescher, B.; Nelson, E. W.; Jacobs, J. L. In Handbook of Pharmaceutical Controlled Release Technology; Wise, D. L., Ed.; Marcel Dekker: New York, 2000; Chap 7.
15. Vueba, M. L.; Pina, M. E.; Veiga, F.; Sousa, J. J.; Batista de Carvalho, L. A. E. Int J Pharm 2006, 307, 56-65.
16. www.isis.rl.ac.uk.
17. Mura, P.; Manderioli, A.; Bramanti, G.; Furlanetto, S.; Pinzauti, S. Int J Pharm 1995, 119, 71-79.
18. Ribardière, A.; Tchoreloff, P.; Couarraze, G.; Puisieux, F. Int J Pharm 1996, 144, 195-207.
19. Ju-Hyun, K.; Hoo-Kyun, C. Int J Pharm 2002, 236, 81-85.
20. Vueba, M. L.; Batista de Carvalho, L. A. E.; Veiga, F.; Sousa, J. J.; Pina, M. E. Eur J Pharm Biopharm 2004, 58, 73-81.